| Assay ID | Title | Year | Journal | Article |
|---|
| AID349233 | Antimicrobial activity against Bacillus cereus by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID349229 | Antimicrobial activity against Streptococcus mitis by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID349224 | Antimicrobial activity against methicillin-resistant Staphylococcus aureus MC1 by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID380079 | Cytotoxicity against human A2780 cells by clonogenic assay | 2006 | Journal of natural products, Feb, Volume: 69, Issue:2
| Cytotoxic and other compounds from Didymochlaena truncatula from the Madagascar rain forest. |
| AID349225 | Antimicrobial activity against methicillin-resistant Staphylococcus aureus MC2 by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID1354540 | Antiinflammatory activity in mouse J774 cells assessed as reduction in LPS-induced nitric oxide production after 24 hrs by Griess assay | 2018 | Journal of natural products, 05-25, Volume: 81, Issue:5
| Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner. |
| AID1354541 | Antiinflammatory activity in mouse J774 cells assessed as reduction in LPS-induced IL6 expression after 24 hrs by ELISA | 2018 | Journal of natural products, 05-25, Volume: 81, Issue:5
| Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner. |
| AID349230 | Antimicrobial activity against Streptococcus agalactiae by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID1110759 | Nematocidal activity against Caenorhabditis elegans assessed as mortality | 2002 | Annual review of phytopathology, , Volume: 40 | Phytochemical based strategies for nematode control. |
| AID349236 | Antimicrobial activity against Bacillus anthracis Sterne by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID1272529 | Antagonist activity at human TRPV1 expressed in HEK293 cells assessed as inhibition of capsaicin-induced increase of intracellular calcium level | 2016 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
| TRPA1 channels as targets for resveratrol and related stilbenoids. |
| AID1272525 | Agonist activity at human TRPV1 expressed in HEK293 cells assessed as induction of intracellular calcium level relative to allyl isothiocyanate | 2016 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
| TRPA1 channels as targets for resveratrol and related stilbenoids. |
| AID248171 | inhibitory concentration against PGE-2 production in LPS-stimulated RAW264.7 cells | 2004 | Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
| Synthesis and inhibitory effects of pinosylvin derivatives on prostaglandin E2 production in lipopolysaccharide-induced mouse macrophage cells. |
| AID1272527 | Antagonist activity at human TRPV1 expressed in HEK293 cells | 2016 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
| TRPA1 channels as targets for resveratrol and related stilbenoids. |
| AID1467690 | Agonist activity at human TRPA1 expressed in HEK293 cells assessed as induction of calcium influx at 30 uM after 6 mins by Fluo-4 dye-based assay relative to AITC | 2017 | Bioorganic & medicinal chemistry letters, 07-15, Volume: 27, Issue:14
| Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor. |
| AID1272526 | Antagonist activity at human TRPV1 expressed in HEK293 cells assessed as inhibition of allyl isothiocyanate-induced increase of intracellular calcium level | 2016 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
| TRPA1 channels as targets for resveratrol and related stilbenoids. |
| AID1354538 | Inhibition of PI3K/Akt in mouse J774 cells assessed as reduction in LPS-induced Akt phosphorylation at Ser473 after 4 hrs by Western blot analysis | 2018 | Journal of natural products, 05-25, Volume: 81, Issue:5
| Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner. |
| AID349240 | Antimicrobial activity against vancomycin-resistant Enterococcus faecium 14 by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID1354542 | Antiinflammatory activity in mouse J774 cells assessed as reduction in LPS-induced MCP1 expression after 24 hrs by ELISA | 2018 | Journal of natural products, 05-25, Volume: 81, Issue:5
| Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner. |
| AID1467689 | Inhibition of human TRPA1 expressed in HEK293 cells assessed as decrease in AITC-induced calcium influx at 30 uM preincubated for 6 mins followed by AITC addition measured for 1 min by Fluo-4 dye-based assay relative to resveratrol | 2017 | Bioorganic & medicinal chemistry letters, 07-15, Volume: 27, Issue:14
| Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor. |
| AID349237 | Antimicrobial activity against Mycobacterium bovis BCG by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID349241 | Antimicrobial activity against Mycobacterium smegmatis by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID349220 | Antimicrobial activity against Corynebacterium diphtheriae Tox by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID977599 | Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM | 2013 | Molecular pharmacology, Jun, Volume: 83, Issue:6
| Structure-based identification of OATP1B1/3 inhibitors. |
| AID349235 | Antimicrobial activity against Bacillus subtilis by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID349222 | Antimicrobial activity against Staphylococcus aureus ATCC 29213 by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID349232 | Antimicrobial activity against Streptococcus pneumoniae ATCC 49619 by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID1272528 | Antagonist activity at TRPV1 (unknown origin) in DRG neurons | 2016 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
| TRPA1 channels as targets for resveratrol and related stilbenoids. |
| AID1081917 | Antifungal activity against Diaporthe ampelina assessed as growth inhibition after 120 hr by NCCLS M27-A broth microdilution method | 2011 | Journal of agricultural and food chemistry, Mar-09, Volume: 59, Issue:5
| Biological activity of peanut (Arachis hypogaea) phytoalexins and selected natural and synthetic Stilbenoids. |
| AID349231 | Antimicrobial activity against Streptococcus pyogenes by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID1081915 | Antifungal activity against Phomopsis obscurans assessed as growth inhibition at 30 uM after 144 hr by NCCLS M27-A broth microdilution method | 2011 | Journal of agricultural and food chemistry, Mar-09, Volume: 59, Issue:5
| Biological activity of peanut (Arachis hypogaea) phytoalexins and selected natural and synthetic Stilbenoids. |
| AID349226 | Antimicrobial activity against vancomycin-resistant Enterococcus faecium 1 by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID1272524 | Agonist activity at rat TRPA1 expressed in HEK293 cells assessed as induction of intracellular calcium level relative to allyl isothiocyanate | 2016 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
| TRPA1 channels as targets for resveratrol and related stilbenoids. |
| AID349234 | Antimicrobial activity against Bacillus megaterium by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID977602 | Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM | 2013 | Molecular pharmacology, Jun, Volume: 83, Issue:6
| Structure-based identification of OATP1B1/3 inhibitors. |
| AID1272523 | Agonist activity at rat TRPA1 expressed in HEK293 cells assessed as induction of intracellular calcium level | 2016 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
| TRPA1 channels as targets for resveratrol and related stilbenoids. |
| AID349239 | Antimicrobial activity against Pseudomonas aeruginosa by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID349228 | Antimicrobial activity against Listeria monocytogenes by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID349227 | Antimicrobial activity against Enterococcus faecalis ATCC 29212 by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID1081919 | Octanol-water partition coefficient, log P of the compound by HPLC analysis | 2011 | Journal of agricultural and food chemistry, Mar-09, Volume: 59, Issue:5
| Biological activity of peanut (Arachis hypogaea) phytoalexins and selected natural and synthetic Stilbenoids. |
| AID349223 | Antimicrobial activity against Staphylococcus aureus ATCC 25923 by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID1272522 | Antagonist activity at rat TRPA1 expressed in HEK293 cells assessed as inhibition of allyl isothiocyanate-induced increase of intracellular calcium level | 2016 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
| TRPA1 channels as targets for resveratrol and related stilbenoids. |
| AID349221 | Antimicrobial activity against Corynebacterium pseudodiphtheriticum by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID349238 | Antimicrobial activity against Escherichia coli by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID349219 | Antimicrobial activity against Corynebacterium xerosis by NCCLS M7-A6 method | 2008 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
| New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1159550 | Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening | 2015 | Nature cell biology, Nov, Volume: 17, Issue:11
| 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. |
| AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6
| A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |